Cargando…
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Combining stem cells with biomaterial scaffolds provides a promising strategy for the development of drug delivery systems. Here we propose an innovative immunotherapeutic organoid by housing human mesenchymal stromal cells (MSCs), gene-modified for the secretion of an anti-CD33-anti-CD3 bispecific...
Autores principales: | Aliperta, Roberta, Welzel, Petra B., Bergmann, Ralf, Freudenberg, Uwe, Berndt, Nicole, Feldmann, Anja, Arndt, Claudia, Koristka, Stefanie, Stanzione, Marcello, Cartellieri, Marc, Ehninger, Armin, Ehninger, Gerhard, Werner, Carsten, Pietzsch, Jens, Steinbach, Jörg, Bornhäuser, Martin, Bachmann, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311951/ https://www.ncbi.nlm.nih.gov/pubmed/28205621 http://dx.doi.org/10.1038/srep42855 |
Ejemplares similares
-
Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts
por: Aliperta, R, et al.
Publicado: (2015) -
Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
por: Bachmann, Dominik, et al.
Publicado: (2017) -
Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8
por: Michalk, Irene, et al.
Publicado: (2014) -
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells
por: Koristka, Stefanie, et al.
Publicado: (2019) -
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
por: Feldmann, Anja, et al.
Publicado: (2017)